Laboratory Studies

Based on the excess precursors formed by the enzyme deficiency, diagnosis is made by measuring 11-deoxycortisol.^[13]

Random levels of 11-deoxycortisol are markedly elevated (to several thousand ng/dL) in the classic form. In subjects with the late-onset (nonclassic) variants, random levels of 11-deoxycortisol may be normal; thus, an ACTH stimulation test to demonstrate elevated poststimulation values is then indicated (see Adrenocorticotropin [ACTH] and Dexamethasone/Corticotropin-Releasing Hormone Test).

In the classic form, other hormones that may be elevated include deoxycorticosterone (DOC), urinary 17-ketosteroids, urinary tetra hydrometabolites, adrenal androgens (including dehydroepiandrosterone [DHEA], dehydroepiandrosterone sulfate [DHEA-S], and androstenedione), and testosterone.^[14]

Because DOC and other precursors associated with 11-beta-hydroxylase deficiency have mineralocorticoid activity, plasma renin activity is suppressed. Neonates may lack the diagnostic features of hypertension and suppressed renin.

Mild to moderate elevations of 17-hydroxyprogesterone may be observed (see 17-Hydroxyprogesterone, Serum and 17-Hydroxyprogesterone, Urine); thus, a diagnosis of 11-beta-hydroxylase deficiency may be missed in neonates if 11-deoxycortisol is not specifically measured. Although 17-hydroxyprogesterone levels are not markedly elevated, an erroneous diagnosis of 21-hydroxylase deficiency is possible.

In contrast to other forms of CAH, carriers of 11-beta-hydroxylase deficiency (heterozygotes) do not have elevated metabolite precursors.

Once a case has been identified, additional familial cases can be found by using biochemical or genetic markers.

Increased understanding of the genetic basis of this condition has enabled the medical community to establish the diagnosis prenatally.^{[15, 16, 17]} Techniques include estimating amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies. DNA analysis is used routinely in Israel, where the single His R448H mutation is prevalent.

In addition to enabling genetic counseling, prenatal diagnosis of 11-beta-hydroxylase deficiency offers the opportunity to consider prenatal treatment with dexamethasone in order to prevent virilization of the external genitalia of XX fetuses.^{[15, 16, 18]}

In patients with a mild (nonclassic) variant of 11-beta-hydroxylase deficiency, ACTH-stimulated levels of 11-deoxycortisol should be 5 times the normal level.

Imaging Studies

Pelvic or testicular ultrasonography is useful to visualize adnexal structures in the pelvis of females, to check for normal gonads, and to exclude testicular masses.

Testicular adrenal rest tumors (ectopic adrenal tissue) have been described in males. The tumors usually are bilateral, located in the mediastinum testes, and detected by ultrasonography.

Abdominal computed tomography (CT) scanning may be useful for evaluating the adrenal glands, excluding mass lesions, and diagnosing adrenal hyperplasia, which typically is symmetrical and bilateral (and may also be nodular in long-standing cases). Occasionally, adrenal rests can also be found in ectopic retroperitoneal locations.

Treatment & Management

Nour MA, Pacaud D. Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2015. 2015 (1):12. [Medline].
Mornet E, Dupont J, Vitek A. Characterization of two genes encoding human steroid 11 beta- hydroxylase (P-450(11) beta). J Biol Chem. 1989 Dec 15. 264(35):20961-7. [Medline]. [Full Text].
Joehrer K, Geley S, Strasser-Wozak EM. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hum Mol Genet. 1997 Oct. 6(11):1829-34. [Medline]. [Full Text].
Zhu YS, Cordero JJ, Can S, et al. Mutations in CYP11B1 gene: phenotype-genotype correlations. Am J Med Genet A. 2003 Oct 15. 122(3):193-200. [Medline].
Xu C, Qiao J, Liu W, Jiang X, Yan F, Wu J, et al. Identification and functional characterization of a large deletion of the CYP11B1 gene causing an 11ß-Hydroxylase deficiency in a Chinese pedigree. Horm Res Paediatr. 2012. 78(4):212-7. [Medline].
Wang X, Nie M, Lu L, Tong A, Chen S, Lu Z. Identification of seven novel CYP11B1 gene mutations in Chinese patients with 11β-hydroxylase deficiency. Steroids. 2015 Aug. 100:11-6. [Medline].
Pascoe L, Curnow KM, Slutsker L. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A. 1992 Jun 1. 89(11):4996-5000. [Medline]. [Full Text].
Davies E, Mackenzie SM, Freel EM, et al. Altered corticosteroid biosynthesis in essential hypertension: a digenic phenomenon. Mol Cell Endocrinol. 2008 Sep 19. [Medline].
Rosler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet. 1992 Apr 1. 42(6):827-34. [Medline].
Khattab A, Haider S, Kumar A, et al. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2017 Mar 7. 114 (10):E1933-40. [Medline].
Reisch N, Högler W, Parajes S, Rose IT, Dhir V, Götzinger J, et al. A diagnosis not to be missed: Non-classic steroid 11ß-hydroxylase deficiency presenting with premature adrenarche and hirsutism. J Clin Endocrinol Metab. 2013 Aug 12. [Medline].
Storr HL, Barwick TD, Snodgrass GA, et al. Hyperplasia of adrenal rest tissue causing a retroperitoneal mass in a child with 11 beta-hydroxylase deficiency. Horm Res. 2003. 60(2):99-102. [Medline].
Peter M, Janzen N, Sander S, et al. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS. Horm Res. 2008. 69(4):253-6. [Medline].
Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 3. Characterization, using GC-MS and GC-MS/MS, of androstanes and androstenes. Steroids. 2012 Nov. 77(13):1487-501. [Medline].
Carlson AD, Obeid JS, Kanellopoulou N. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol. 1999 Apr-Jun. 69(1-6):19-29. [Medline].
Cerame BI, Newfield RS, Pascoe L, et al. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab. 1999 Sep. 84(9):3129-34. [Medline]. [Full Text].
Rosler A, Leiberman E, Rosenmann A, et al. Prenatal diagnosis of 11beta-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1979 Oct. 49(4):546-51. [Medline].
Van Vliet G, Polak M, Ritzén EM. Treating fetal thyroid and adrenal disorders through the mother. Nat Clin Pract Endocrinol Metab. 2008 Dec. 4(12):675-82. [Medline].
German A, Suraiya S, Tenenbaum-Rakover Y, et al. Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy. J Clin Endocrinol Metab. 2008 Dec. 93(12):4707-10. [Medline].
Mantero F, Opocher G, Rocco S. Long-term treatment of mineralocorticoid excess syndromes. Steroids. 1995 Jan. 60(1):81-6. [Medline].
Garner PR. Congenital adrenal hyperplasia in pregnancy. Semin Perinatol. 1998 Dec. 22(6):446-56. [Medline].
Meyer-Bahlburg HF. What causes low rates of child-bearing in congenital adrenal hyperplasia?. J Clin Endocrinol Metab. 1999 Jun. 84(6):1844-7. [Medline]. [Full Text].
Burgu B, Duffy PG, Cuckow P, et al. Long-term outcome of vaginal reconstruction: comparing techniques and timing. J Pediatr Urol. 2007 Aug. 3(4):316-20. [Medline].
Azziz R. Nonclassic adrenal hyperplasia. Bardin CW, ed. Current Therapy in Endocrinology and Metabolism. 6th ed. St Louis, Mo: Mosby-Yearbook; 1997. 175-8.
Azziz R, Boots LR, Parker CR Jr. 11 beta-hydroxylase deficiency in hyperandrogenism. Fertil Steril. 1991 Apr. 55(4):733-41. [Medline].
Cathelineau G, Brerault JL, Fiet J, et al. Adrenocortical 11 beta-hydroxylation defect in adult women with postmenarchial onset of symptoms. J Clin Endocrinol Metab. 1980 Aug. 51(2):287-91. [Medline].
Deaton MA, Glorioso JE, McLean DB. Congenital adrenal hyperplasia: not really a zebra [published erratum appears in Am Fam Physician 1999 Sep 15;60(4):1107]. Am Fam Physician. 1999 Mar 1. 59(5):1190-6, 1172. [Medline]. [Full Text].
Ghazi AA, Hadayegh F, Khakpour G, et al. Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia. J Endocrinol Invest. 2003 Jan. 26(1):84-7. [Medline].
Kalaitzoglou G, New MI. Congenital adrenal hyperplasia. Molecular insights learned from patients. Receptor. 1993 Fall. 3(3):211-22. [Medline].
Lucky AW, Rosenfield RL, McGuire J, et al. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 1986 May. 62(5):840-8. [Medline].
Mantero F, Opocher G, Armanini D. 11 Beta-hydroxylase deficiency. J Endocrinol Invest. 1995 Jul-Aug. 18(7):545-9. [Medline].
Merke DP, Tajima T, Chhabra A. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab. 1998 Jan. 83(1):270-3. [Medline]. [Full Text].
Miller WL. Congenital adrenal hyperplasia in the adult patient. Adv Intern Med. 1999. 44:155-73. [Medline].
Miller WL. Early steps in androgen biosynthesis: from cholesterol to DHEA. Baillieres Clin Endocrinol Metab. 1998 Apr. 12(1):67-81. [Medline].
Moran C, Knochenhauer ES, Azziz R. Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal. J Endocrinol Invest. 1998 Nov. 21(10):707-20. [Medline].
New MI, Newfield RS. Congenital adrenal hyperplasia. Bardin CW, ed. Current Therapy in Endocrinology and Metabolism. 6th ed. St Louis, Mo: Mosby-Yearbook; 1997. 179-187.
Pang S. Congenital adrenal hyperplasia. Baillieres Clin Obstet Gynaecol. 1997 Jun. 11(2):281-306. [Medline].
Pang S, Levine LS, Lorenzen F. Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Mar. 50(3):586-9. [Medline].
Panitsa-Faflia C, Batrinos ML. Late-onset congenital adrenal hyperplasia. Ann N Y Acad Sci. 1997 Jun 17. 816:230-4. [Medline].
Stratakis CA, Rennert OM. Congenital adrenal hyperplasia: molecular genetics and alternative approaches to treatment. Crit Rev Clin Lab Sci. 1999 Aug. 36(4):329-63. [Medline].
White PC. Genetic diseases of steroid metabolism. Vitam Horm. 1994. 49:131-95. [Medline].
White PC. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am. 2001 Mar. 30(1):61-79, vi. [Medline].
White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev. 1994 Aug. 15(4):421-38. [Medline].
White PC, Obeid J, Agarwal AK. Genetic analysis of 11 beta-hydroxysteroid dehydrogenase. Steroids. 1994 Feb. 59(2):111-5. [Medline].
White PC, Speiser PW. Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am. 1994 Jun. 23(2):325-39. [Medline].
Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983 Feb. 56(2):222-9. [Medline].